ESR1 and breast carcinoma: With regard to the role of autophagy in ER positive/Her 2 negative breast cancer undergoing combination treatment of Letrozole + Palbociclib or Fulvestrant + Palbociclib, additional pre-clinical studies are needed to support implementation of clinical trials.